Trilantic North America announced it will make a growth investment in SOFIE Biosciences. 

SOFIE, founded in 2008 and based in Dulles, Virginia, is a radiopharmacy and contract development and manufacturing organization.

Trilantic Capital Management (Trilantic North America), founded in 2009 and based in New York, is a growth-focused middle market private equity firm that pursues control and significant minority investments in North America. The firm’s primary investment focuses are the business services and consumer sectors. 

Terms of the investment were not disclosed.